miR-200c inhibits tumor metastasis by downregulating the expression of the transcription factor c-Jun and MRTF/SRF, which in turn interferes with the expression of the cytoskeletal protein filamin A, thereby reducing the motility of tumor cells [25]. Here, SRF is linked to neoplasm.